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Study of the specific antigens of mouse leukemias has advanced considerably 
in recent years, largely as a  result of the development of effective methods of 
serological analysis in vitro (1, 2). Of the various antigens that can be demon- 
strated in leukemia cells of the mouse, the G (Gross) antigen (3, 4) is of partic- 
ular interest because of its widespread distribution among leukemias of natural 
occurrence (4-6). The G antigen is demonstrable by the cytotoxic test in vitro, 
and is found in: (a) the cells of leukemias induced by Passage A Gross virus; (b) 
the cells of leukemlas arising in mice of strains with a  high incidence of leu- 
kemia,--AKR,  AKR.K,  C58,  PL,  F,  and  C3Hf/Figge-Law; (c)  the  normal 
lymphoid tissues of these high-incidence strains (which we therefore refer to as 
G+ strains), but not of low-incidence strains (G- strains); and (d) some leu- 
kemias and solid tumors of low-incidence strains.  The  presence  of G  cellular 
antigen indicates infection by Gross vLms and provides a means to identify the 
etiology of leukemias induced by Gross virus. 
In a further investigation of the G antigenic system, we have made a  study 
of leukemias induced in inbred rats by virus from non]eukemic C58 mice, which 
are naturally infected with leukemia virus. In contrast to leukemias induced by 
Gross virus in the mouse (either as a result of natural infection or by inoculation 
of Passage A virus) these rat leukemias are highly antigenic and are not trans- 
plantable to axiult isogenic recipients. The serum of adult rats that have resisted 
transplants  of isogenic leukemias contMns cytotoxic and precipitating anti- 
bodies to antigens belonging to the G system. With these antisera it has been 
possible to conduct a more extensive analysis of the G (Gross) antigenic system, 
which is now seen to comprise a complex group of distinct antigens. 
* Supported by Grants CA 06338 and CA 08748 from the National Cancer Institute, 
National Institutes of Health, United States Public Health Service, and a grant from the 
John A. Hartford Foundation~  Inc. 
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Materials and Methods 
Rats.---Our colony of  W/Fu inbred rats  (7)  originated from a  litter provided by Dr.  J. 
Furth in 1961  and is now in the 10th generation of inbreeding in this laboratory. Thirteen 
spontaneous leukemias have been observed during this period, an incidence of the order of 
5% in animals kept for 18 months or longer. According to the criteria of  (a) acceptance of 
skin grafts, and  (b) invariable transplantability of spontaneous leukemias, the strain is ho- 
mogeneous. The colony of BN  [Brown Norway) rats is descended from a  litter provided by 
Dr. R. E. Billingham and Dr. W. K. Silvers in 1964. 
Mouse Leukem/~s.--The spontaneous and induced mouse leukemias used for serological 
tests and for inoculation into newborn rats, arose in mice of our own colonies and were trans- 
planted only in these mice. Methods of inducing leukemia by X-radiation, by chemical car- 
cinogens, and by viruses [Gross Passage A  (8), Friend (9), Moloney (10), and Rauscher (11)] 
are recorded in previous publications from this laboratory. 
Inoculation of Newborn Rats.--Rats less than 24 hr old were inoculated either with viable 
cell suspensions of normal or leukemic mouse tissue or with filtrates of leukemic tissue. Cell 
suspensions were prepared from the thymus of normal C58 mice or from organs of leukemic 
mice (thymus, spleen, and lymph nodes) by mincing with curved scissors in Earle's balanced 
salt solution (EBSS). The released ceils were washed and resuspended in medium 199; via- 
bility was determined by counting in the presence of trypan blue, which invariably showed 
that less than 10% of the cells were dead. Cell-free extracts were obtained by filtration (Selas 
02) of a  20% (v/v) homogenate of leukemic tissue that had first been clarified by centrifu- 
gation at 2000 g for I hr. Newborn rats received 0.25 ml of these filtrates either subcutane- 
ously or intraperitoneally. 
Antisera.--Sernm  was obtained by bleeding from the tail under ether anesthesia and  was 
stored at -  70°C. 
Cytotoxic Test (12, 13).--Serial dilutions (0.05 ml) of rat antiserum, (inactivated at 56°C 
for 30 rain) were incubated with cells (0.05  ml of a  suspension containing 5  X  106 eells/ml) 
and pooled guinea pig serum diluted ~  (0.05  ml) to provide C'. After incubation for 45 min 
at 37"C, trypan blue was added and a count of stained and unstained cells was made. Titers 
refer to the dilution of antiserum in which the proportion of dead cells (stained) was nearest 
to 50%. In every test, cells were incubated also in: (a) antiserum alone, (b) guinea pig serum 
alone; these showed no more than 10% stained cells.  The diluent was medium 199. 
Typing  by Absorption.--The  typing of tissues for G  antigen was performed according to 
the absorption procedure outlined previously  (4).  With this technique, a  typing antiserum 
of known titer against a  selected standard G-t- cell line is diluted to two 2-fold dilutions be- 
low the endpoint and absorbed with equal volumes of packed washed cells of the tissue to be 
tested. The mixture is incubated for 45 min at room temperature followed by 45 min at 4°C, 
with occasional resuspension, and  the serum is recovered by centrifugation. The absorbed 
serum is then tested for residual activity on the standard G-t- cells.  Absence of cytotoxic 
activity shows that the cells used for absorption contain G antigen. 
Immunodiffusion.--Double-diffusion  (Ouchterlony) tests were  performed on slides in 2% 
Noble agar  (Immunoplate pattern  C,  Hyland Laboratories, Los Angeles). The slides were 
left at room temperature and inspected over a  4  day period.  Optimal precipitation usually 
occurred by 18 to 24 hr. 
Preparation of Antigen for Immunodiffusion.-- 
Soluble antigen from cells or plasma: Suspensions of normal cells or leukemia cells were 
prepared  by mincing tissues with curved scissors in EBSS and discarding the larger frag- 
ments that settled rapidly.  The cells were  washed  twice by slow centrifugation to  obtain 
whole cells free of debris. They were then packed at 2000 g for 10 rain, resuspended in 1 to 5 
volumes of EBSS, and disrupted by 3 cycles of freezing and thawing or by means of a  Vertis GAYLA GEERING, LLOYD J.  OLD, AND EDWARD A.  BOYSE  755 
"45" high speed homogenizer  (medium speed for 3 min). This material was spun at 2000 g 
for 45 rain and the sediment was discarded. The superuate, or heparinized plasma, was then 
spun at 100,000 g for 1 hr in a Beckman  L-2 centrifuge  (type 50 rotor). This supernate was 
reduced to ~5  to ~o  of its originai volume either by vacuum dialysis (Carl Schieicher  & 
Schuell, Keane, New Hampshire) or by placing it in dialysis tubing (Visking diaiysis mem- 
brane, size 8, Union Carbide, New York) surrounded  by Sephadex  G-100. The protein con- 
tent of the tiual extracts (280 mtt absorbance, ovalbumin standard) varied considerably ac- 
cording to the tissue extracted, ranging from 50 to 250 mg/ml (both Gq- and G-- prepara- 
tions). In the case of plasma, the volume was reduced to approximately ~  of its original 
volume. These procedures were carried out in the cold. Storage of antigen in the frozen state 
did not lead to loss of precipitating activity. 
Viral antigens: Infective plasma was obtained from: (a) C3Hf/Bi mice with primary lcu- 
kemia induced by Passage A Gross virus, (b) BALB/c mice with primary Rauscher leukemia, 
(c)  W/Fu rats with primary leukemia induced by Moloney virus (lot No. 3042-70 Chas. 
Pfizer and Co., Maywood, New Jersey), and (d) DBA/2 mice infected with Friend leukemia 
virus (kindly provided by Dr. Charlotte Friend, Sloan-Kettering Institute for Cancer Re- 
search).  Pellets of virus were obtained from 10 to 20 ml of fresh plasma by centrifugation at 
100,000 g for 1 hr. Mammary tumor virus (MTV) prepared from infective milk of RIII mice 
by density-gradient centrifugation was kindly provided by Dr. D. Moore, Rockefeller Uni- 
versity. Viral pellets from these various sources were dispersed in 0.1 to 0.15 mi EBSS and 
examined by immunodiffusion either untreated or after exposure to ether. Exposure  to ether 
was effected by placing 0.05 to 0.1 ml of the resuspended peUet in a glass beaker (internal 
diameter, 27 ram)  and adding 2 mi ether (Squibb,  anesthesia grade). The mixture was left 
at room temperature and shaken frequently until the ether had evaporated (usually less than 
10 rain). The residue was placed on ice if it was to be used on the same day, or was stored 
at -- 70°C. 
RESULTS 
Induction of Leukemias in W/Fu Inbred Rats by Inoculation  of Viable Mouse 
Cells or by Filtrates.--A variety of viable mouse ceils, normal or leukemic, or 
filtrates, were inoculated into newborn W/Fu  inbred rats. Table  I  and  Table 
II  summarize the results of these experiments. In the case of viable leukemia 
cells, three types of  response were observed: (a) progressive growth  of inocu- 
lated mouse leukemias, leading to death of the host 2 to  3  wk later; (b) inoc- 
ulated cells did not grow  progressively, but  the  recipients developed primary 
leukemia in  adult life (identified histologically as lymphoblastic); and  (c)  no 
leukemia developed, of either mouse or rat origin, during observation  periods 
of 1 yr or more. 
Those cell types and  filtrates that induced primary leukemia on inoculation 
into newborn rats are listed in Table I. Normal thymus cells from the G-k C58 
strain were particularly effective; of 19 newborn rats inoculated with 30 to 50 X 
10 e washed thymus cells from C58 mice aged 6 to 8 wk, 15 developed leukemia. 
In subsequent experiments the incidence was as high as 100%. Leukemia cells, 
or filtrates of leukemia cells, from the high-incidence Gq- AKR strain also were 
highly  effective.  Cells  from  3  leukemias  of  mice  of  G--  strains--DBA/2, 
BALB/c  and  (C57BL/6  X  A)Fl--induced primary leukemias in W/Fu  rats 
(last 3 entries in Table I). With these exceptions, the inoculation of viable cells TABLE  I 
Induction of Leukemia in W/Fu Inbred Rats by Neonatal Inoculation of Viable Mouse Cells or 
Filtrates of Mouse Cells 
Transplantability of primary 
Inoculum  W/Fu leukemia~ 
In- 
cidence  Latent period from time 
G  of  of inoculation to devel-  W/Fu rats 
Orion of cells  (trans-  antigen  Leu-  plant generation)  i  type  No. of  Route  leu-  opment of leukemia--  kemia  Mice 
reference  cells  kemia*  tested  <:7 days  adult 
4)  old 
(× lo e) 
AKR~ 
Spontaneous  leu-  G+  140  s.c. 
kemia (0)  5/6 
140  i.p. 
AKR9 
Spontaneous leu- 
kemia (0) 
AKR9 
Leukemia DMBA 
2 (4) 
AKR9 
Leukemia U7 (0) 
G-{-  100  s.c.  1/5 
G-l-  Fil-  s.c.  2/5 
trat~ 
G~  Fil-  s.c.  4/10 
trate 
C58~ 9  (6 to 8 wk 
old) 
Thymus  -G-4-  30  i.p.  5/8 
_G-t-  50  i.p.  10/11 
DBM2 9 
Leukemia DMBA  G-I- 
lS (S) 
BALB/c 
Spontaneous ]eu-  Not 
kemia (4)  tested 
(C57BL/5  X  A)F1 
Leukemia Ull (2) 
days 
55 (~A)  A  --  -I- 
62 (gB)  B  +  -- 
152 (~C), 189 (~D)  C, D 
189 (gE) 
1 NL at 12 months 
s8  (gF)  ffi 
W/Fu (AKR-SL)F 
4 NL at 6 months 
F  +  -- 
132 (o~1), 138 (~2)  1, 2  -~-, -~- 
3 NL at 12 months 
127 (~I), 144  (d2) 
223 (~3) 
223 (~  4) 
6 NL at 12 months 
Z  ÷ 
142 (%), 146 (dA),  A, B 
214 ( 9 B) 
225 (~), 255 (dC)  C  -~  -- 
3 NL at 117, 161 and 
183 days 
173 (~D) =  D 
W/Fu (C58NT)D 
179 (gE), 204 (dF)  E, F, 
209 (riG)  G 
204 (~H)  H 
258 (¢ I)  =  I 
W/Fu (C~SNT)I 
259 (~J), 276 (~K) 
276 (~L) 
290 (~M)  M 
1 1VL at 12 months 
÷ 
--~, -[% 
+ 
+ 
+ 
+ 
+ 
32  i.p.  1/1  228 (dA)  A  --  -[-  -- 
50  s.c.  4/8  213 (~A), 220 (o~B)  A, B 
328 (~C), 330 (~D)  C, D  -I-, -t- 
4 NL at 20 months 
Not  187  s.c.  3/7 
tested 
190  (gA), 203 (gB)  A,  B 
210  (dC)  C  --  -- 
4 NL at 12 months 
Abbreviations: NL, not leukemic; i.p., intraperitoneal]y; s.c., subcutaneously; (for abbreviations used in designating 
leukemias, see Table II). 
* Excluding all rats in which the inoculated mouse cells grew progressively. 
:~ -I-, progressive growth; --, no progressive  growth: tested by inoculation of 5 to 50 X  107 cells i.p. into 1 to 4 adult 
rats (depending upon availability of cells and animals); appro~mately  5 X 107 cells i.p. or s.c. into 3 to 10 rats <:7 days 
old; 5 to 25 X  107 cells i.p. into adult mice. One primary leukemia inoculated sc into adult rats was seen to grow tem- 
porarily and then regress. 
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TABLE II 
Summary of Experiments  in Which Newborn W /Fu Rats Inoculated with Viable Mouse Leukemia 
Cells or with Filtrates of Mouse Leukemia Cells, Failed D Devdop Primary Leukemias 
Leukemia* (transplant  generation) 
No.s~  o 
~vo~ 
No. of  cells  Route  Period of observation 
No. rats 
inoculated 
X  10  e 
Radiation-induced 
BALB  o~RL1  (12)  30  s.c.  0/2 
30  i.p.  0/2 
(BALB X  C3H/An)Flo~RAD1  40 
(o) 
s.c.  4/4  4  NL§  at  >20  montl~ 
Ec~RL9 (6 and 7)  110  s.c. 
110  i.p. 
o/4 
Eo~ RL9 (8)  50  i.p.  0/4 
ERLD  (43)  30  s.c.  0/3 
ERLD  (43)  16  s.c.  1/3  1 NL at  18  months 
EARAD1  (69)  25  i.p.  0/3 
RADAI (sg)  20-40  s.c. or  0/14 
i.p. 
RADA2 (29)  16  s.c.  3/3  3  NL  at  :>15  month 
16  i.p.  0/4 
RADA2 (29)  Filtrate  s.c.  17/17  17 NL at  :>15  month~ 
Spontaneous 
E~SL1 (3)  20  s.c.  9/9  1 NL at  13  months 
8  NL  at  :>22  montll 
E~SL1 (3)  113  s.c. 
113  i.p. 
6/6  6  NL at 20 months 
DBA 2 ~ SL1 (11)  37  s.c. 
37  i.p. 
o/s 
DBA 2 ~ SL1 (24)  Filtrate  i.p.  9/9  9  NL  at  >14  months 
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TABLE II--Comluded 
Leukemia* (transplant  generation) 
Spontaneous, cont'd 
DBA 2CSL2 (4) 
DBA/2d'SL2 (19) 
Chemically induced 
(BALB X C3H/An)F~ 9 U5 (3) 
EAd'U6 (1) 
EACU8 (2) 
DBA/2o~DMBA4 (27) 
DBA/2oZDMBA5 (11) 
DBA/2 9 DMBA6 (13) 
DBA/2oZDMBA6 (33) 
DBA 2 9 DMBA15 (5) 
DBA/2 9 DMBA16 (14) 
DBA/2 9 DMBA16 (14) 
DBA/2 ~ DMBA16 (20) 
Route 
1.p. 
S.C. 
S.C. 
S.C. 
S.C. 
S.C. 
l•p. 
Lp. 
S.C. 
Lp. 
S.C. 
l.p. 
S.C. 
l.p. 
Lp. 
vivorsI 
0/10 
6/6 
lO/lO 
11/11 
8/9 
0/5 
12/12 
3/3 
0/5 
10/10 
O/lOj 
4/4 
0/2 
9/9 
Period of observation 
6  NL  at  >12  months 
I 
10 NL at 21  months 
1 NL at 13 months 
10 NL at  >20 months 
8  NL  at  >21  months 
12 NL at  >12  months 
3 NL at > 12 months 
10 NL at  >12  months 
4  NL  at  >17  months 
9  NL  at  >17  months 
* The abbreviations  used in designating leukemias are: A, A strain; E, C57BL/6;  EA' 
(C57BL/6  X  A)FG BN, Brown Norway rat; F, Friend; M,  Moloney; R, Rauscher;  SL' 
spontaneous  leukemia;  DMBA,  induced  by  9,10-dimethyl-l,2-benzanthracene; RL  or 
RAD, induced by X-radiation; U, induced by urethan. 
Survivors: refers to those rats that did not succumb to progressive growth of the inocu- 
lated mouse leukemia cells. 
§ NL, not leukemic• 
or filtrates from leukemias of mice of G-- strains (whether G-- or G+)  either 
failed to induce primary leukemias or, in the case of viable cells, gave rise to 
progressively growing transplants (Table II). 
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(a) failure to grow on transplantation to adult rats; this distinguishes them from 
spontaneous W/Fu leukemias, which grow invariably in W/Fu rats of all ages; 
(b) commonly, massive involvement of the thymus, which was not seen with 
the 13 spontaneous  W/Fu leukemias we have observed;  (c) failure to grow on 
transplantion to mice of the same strain that provided the inoculum of cells 
(in those instances where this was tested); and (d) progressive growth on trans- 
plantation to W/Fu rats less than 7 days old. 
The leukemia used most extensively in these studies was W/Fu(C58NT)D. 
(The designation indicates a W/Fu rat leukemia induced by neonatal inocula- 
tion of C58 mouse normal thymus, "D" in the series.) It is identified as a rat 
leukemia not only by the transplantation criteria (Table I) but also by its lack 
of sensitivity to cytotoxic rat anti-mouse serum  (W/Fu anti.G- normal mouse 
tissue) and by the karyotypo, which was identified as rat by Dr. J. Biedler of 
this Institute. 
The serum of rats with primary induced leukemias or transplants of these 
leukemias, or of adult rats that had resisted several inoculations of these leuke- 
mias, contained no HI polyoma antibody (Dr.  B. A. Briody, New Jersey Col- 
lege of Medicine and Dentistry). 
Production of Cytotoxic Antibody by Adult W/Fu Rats Immunized with Iso- 
genic Induced  W/Fu Leukemias Maintained  in Passage in Newborn Itosts.-- 
Several lines 0f induced leukemias were established by serial passage in newborn 
rats. Adult W/Fu rats,  which  rejected transplants of these leukemias,  were 
further immunized by up to 12 intraperitoneal inoculations of 8 X  10  e to 300 X 
l0  s viable leukemia cells over periods of 3 to 8 months. These rats were found to 
develop  antibody that was  cytotoxic for ceils of the leukemia used for im- 
munization and for the cells of all other W/Fu leukemias induced by the same 
method, but not for W/Fu spontaneous leukemias  or for normal ceils from 
W/Fu thymuS, spleen, or lymph nodes. In tests with a variety of mouse ceils, 
normal and leukemic, it appeared that these sera were typing for G antigen. 
Representative cytotoxic tests are recorded in Table III. 
Determination of tke Specificity of tke Cytotoxic Antibody in Immune Rat Serum 
by Absorption Tests.--For purposes of further identifying the specificity of the 
cytotoxic antibody, the serum W/Fu anti-W/Fu(C58NT)D (6 to 12  inocula- 
tions)  was absorbed  with the various  tissues listed in Table IV, and the ab- 
sorbed serum was tested for eytotoxic activity on W/Fu(C58NT)D or I ceils, 
as  described under  Materials and Methods. The presence  or absence  of  G 
antigen in the tissues selected for absorption was in most instances known from 
a previous study (4). (This is determined by absorption  of the G typing serum 
C57BL/6 anti-(AKR)K36 in tests with the transplanted C57BL/6 leukemia 
E cP G2 which was originally induced by Passage A Gross virus.) Table IV in- 
dicates that all GA- tissues, both leukemic and nonleukemic, removed activity 
from the immune rat serum.  (Thymus ceils of GA-  strains, which absorb  G 
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TABLE III 
Some Examples of Direa Cytotoxic Tests With the Serum of W/Fu In~,ed Rats Immunized 
With Isogenic W/Fu Rat Leukemia Cells 
Te~t Cells (transplant generation and 
antigenic type)* 
Dilution of W/Fu anti-W/Fu(C,S8NT)D ser~n 
I/2  1/4  1/8  1/16  1/32  [  1/64 [1/128  1/256 
Dead cells (stained by trypan blue) 
Normal tissues 
Rat (W/Fu) 
Spleen (G-) 
Lymph nodes (G--) 
Mouse (C57BL/6) 
Spleen (G--) 
Lymph nodes (G--) 
Mouse (AKR) 
Spleen (G+) 
Lymph nodes (G+) 
Leukemias 
Rat (W/Fu) spontaneous 
9 SLI (11:  G--) 
9  SL7 (50: G--) 
Rat (W/Fu) induced by 
mouse cells 
C  (C58NT)D (57: G+) 
9  (C58NT)I (10: G+) 
9  (AKR-SL)F (1: G+) 
Mouse 
ERLD (95: G-, FMR--) 
EQSL2 (48: G--, FMR-) 
EL4 (>100: G--, FMR--) 
E 9 R2 (76: G--, FMR+) 
EgG1 (52: G+, FMR-) 
EoZG2 (57: G+, FMR--) 
%  1%  r  %  1%  [  %  J  % 
<10  <10  <10,  <10 
2'1  1'1  33  20  < 10 
<10 I  <10 I  <10 
< 10  < 10  < 10 
 95]  o51  871 ,0  >95  >95  >95  >95 
>95  >95  80  70 
<10 
<10 
<10 
<10 
>95 
>95  I I 
<10  <10 
<10  <10 
< 10  < 10 
>95  >95  91 
>95  >95  '>95 
<10 
<I0 
For abbreviations used in designating leukemias see footnote to Table II. 
*  G:  G  (Gross) leukemia antigen (4). FMR: antigen associated with lemkemias induced 
by Friend, Moloney,  and Rauseher viruses (14). 
and so are recorded as G:J=, did not absorb activity from the rat serum.) In the 
case of G--  tissues, however,  a  number  of exceptions were noted.  In several 
instances, leukemias that were repeatedly found to be G--  in the mouse test 
system absorbed cytotoxic activity from the rat immune serum. Thus  the rat TABLE IV 
Specificity  of tke Serum  W/Fu AnIi-W/Fu(C58NT)D  Tested by Absorption*  With  Various 
Tissues  of Known Antigenic  Type  (G+  or G-) 
Ceils used for absorption 
Normal tissue 
Spleenll 
AKR, AKR.K and C58  G+ 
A, C57BL/6, BALB/c, I and C3H/An (mouse),  G-- 
W/Fu and BN (rat) 
Thymus[[ 
AKR, AKR.K and C58  G-4- 
A, C57BL/6, BALB/c and I  (mouse),  W/Fu  G-- 
and  BN (rat) 
Rat leuhemias 
Induced by inoculation of mouse cells or filtrates 
of AKR leukemia ceils 
W/Fu(C58NT)D ascites (tested repeatedly)  G+ 
W/Fu(C58NT)I (tested repeatedly)  G-{- 
W/Fu(CS8NT)  M  NT 
W/Fu(AKR-D2-filtrate)  No. I  G+ 
W/Fu(AKR-SL)F  G+ 
W/Fu(AKR-U7-filtrate)  No.  2  G+ 
W/Fu(BALB-SL)  D  G-{- 
BN(C58NT) l  NT 
Spontaneous 
W/Fu 9 SL1  G-- 
W/Fu 9 SL4  G-- 
W/Fu  9  SL5  G-- 
W/Fu 9 SL7 (tested repeatedly)  G-- 
Mouse leuk~mias 
Spontaneous 
AKRo~SL  G+ 
AKR K36 ascites (tested repeatedly)  G+ 
AKR.K(H-2a)  SL3  G+ 
Antigenic type~  Result of absorption§ 
(transplant  (transplant 
generation)  generation) 
O) 
(1) 
(o) 
(s) 
(9) 
(8) 
(8) 
+ 
+ 
+ 
+  (1) 
+  (8) 
+  (8) 
NT 
NT 
+  (2) 
-  (11) 
NT 
-  (9) 
+(o) 
+ 
+ 
C58SL5 
DBA/2 9 SL1 
DBA/2 9 SL6 
DBA/2oZSL2 
DBA/2  9  SL4 
ASL1 (tested  repeatedly) 
ASL6 
E~ SL2 
Radiation-induced 
ECRL9 
ECRAD '65S 
(o) 
(3) 
G+ (12)  + 
G% (44)  % 
G-(0)  + 
G- (80)  ± 
G- (1) 
G-  0) 
G- (4O) 
G+ (46)  + 
G+ (3)  + 
(10) 
(10) 
(54) 
(4) 
(38)  +  (47) 
(3) 
(11) 
(46) 
(5o) 
(7) 
(Table IV continued on following page) 
761 TABLE IV---Condud~ 
Antigenic  type~  Result  of absorptlon§ 
Cells used  for absorption  (transplant  (transplant 
generation)  generation) 
Radiation-induced, cont'  d 
Eo~RL4 
RADA1 
RADA2 
ECRAD '65A 
E ~ RAD '65B 
EgRAD '65D 
ERLD (tested repeatedly) 
EgRL9 
E 9 RAD '65C 
ECRAD '65E 
EgRAD  '63J 
E~RAD '65K 
E ~ RAD '65L 
E ~ RAD '65Q 
E 9 RAD '65R 
EARAD1 
BALB ~ RL1 
129CKAD1 
Induced by inoculation of virus 
Gross Passage A 
C3H/Bi~ 
EgG1 
ECG2 (tested repeatedly) 
Rauseher 
EgR2 
BALB/c 
Moloney 
ECM2 
Friend 
Swiss 
Chemically induced 
DBA/2o~DMBA4 
DBA/2 ~ DMBAt5 
DBA/2 ~ DMBA2 
G~  (32) 
G-  (121, 131) 
G-  (53, 79) 
G-- (3) 
G-- (1) 
G-  (2) 
G-- 
G-  (27) 
G-- (I) 
G-- (2) 
G--(0) 
G--(0) 
G-- (2) 
G-- (1) 
G-  (1) 
G-  (111) 
o-  (29) 
G-  (2) 
G+ 
G+ 
G+ 
G~ 
G± 
G- 
G-~ 
G-4- 
G+ 
G± 
DBA/2 9 DMBA6  G-- 
DBA/2 9 DMBA12  G-t- 
DBA/2 ~  DMBA16  G-- 
EIA (tested repeatedly)  G-- 
(0) 
(14) 
(29, 52) 
(o) 
(36) 
(0) 
(49) 
(52) 
(23) 
(46) 
(53) 
(37) 
(>1oo) 
+  (37) 
+  (120, 131) 
+  (79, 82) 
4- (2) 
±  (2) 
-~ (2) 
-- (31) 
-  (i) 
-  (1) 
-(0) 
-(0) 
-  (1) 
-  (i) 
_  (1) 
-  (126) 
-  (32) 
-  (3) 
+(o) 
+  (44) 
+ 
~2, ~) 
+  (79) 
*(0) 
+  (58) 
+  (58) 
+  (36) 
+  (58) 
+  (63) 
+  (42) 
-  (>lOO) 
For abbreviations used in designating leukemias see footnote to Table H. 
* Antiserum diluted to two tubes below end point (doubling dilutions), absorbed with 
tissues listed, and titrated in cytotoxic test with W/Fu(C58NT)D or I ceils. 
Determined by absorption of cytotoxic activity from the G  typing serum (C57BL/6 
a~i-(AKR)K36)  in tests with the C57BL/6 leukemia Ec~G2 induced by Passage A Gross 
virus--see reference 4. 
§--, no absorption; ~, partial absorption; +, complete absorption; and NT, not tested. 
[I Separate absorption tests with each of the tissues listed. 
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system detects all G+  cells and also some cells that are G-,  whereas the mouse 
G  system  detects no cells that  are not detected  in the rat system. 
Thus it appears that not all the specificities indicated by the two systems are identical. 
All doubly positive cells must contain all specificities detected by both systems, but evidently 
some  cells lack a  determinant that is  revealed when they are  tested by absorption in  the 
mouse typing system but not when tested by absorption in the rat typing system. The likely 
explanation of this difference is that at least two specificities are  represented  on  the  cells 
of leukemias induced by  Gross virus--G(a), which is  the  component  detected  by  absorp- 
FIG.  1 a. Center (C), extract of G+  transplanted W/Fu leukemia W/Fu(C58NT)I. 
Antisera:  (1)  W/Fu anti-G+ leukemia W/Fu(C58NT)D;  (2)  W/Fu  anti-G-- normal 
mouse tissue; (3)  C57BL/6 anti-(AKR)K36-mouse G typing serum (reference 4);  (4) BN rat 
anti-G-- spontaneous leukemia W/FuSL7;  and  (5)  W/Fu anti-G+ leukemia W/Fu(AKR- 
SL)F. 
FIG.  1 b.  Center (C), serum W/Fu anti-G+ leukemia W/Fu(C58NT)D. 
Extracts:  (1)  G+  transplanted W/Fu leukemia W/Fu(C58NT)I;  (2)  G+  primary AKR 
leukemias (pooled); (3)  G+  transplanted W/Fu leukemia W/Fu(AKR-SL)F;  (4) G+  trans- 
planted  W/Fu  leukemia  W/Fu(C58NT)D;  and  (5)  G+  transplanted  C57BL/6  leukemia 
(induced by Passage A Gross virus) EoZG2. 
FIG.  1 c.  Center (C), Serum W/Fu anti-G+ leukemia W/Fu(C58NT)D. 
Extracts:  (1)  G+  transplanted  W/Fu  leukemia  W/Fu(C58NT)I;  (2)  G-  transplanted 
C57BL/6 leukemia ERLD;  (3) G--  transplanted C57BL/6 leukemia EL4;  (4) Two G-- pri- 
mary C57BL/6 radiation-induced leukemias (pooled); and (5)  G--  transplanted spontaneous 
W/Fu leukemia W/FuSL7. 
tion in the mouse system,  and  G(b),  which  is  detected  in  the  rat  system.  Leukemias  in- 
duced by Passage A  Gross virus, the lymphoid cells and leukemias of mice  of  G+  strains, 
and the leukemias induced in the rat by G+  mouse cells,  have both antigens. Certain leu- 
kemias, such as the two radiation-induced strain A  leukemias and some of the DBA/2 leu- 
kemias shown in Table IV, contain only G(b) and so are active in absorption in the rat system 
while typing G-- in the mouse system. Thus the rat system extends the possibilities of anal- 
ysis to a further cellular antigenic determinant that is associated with wild-type Gross virus, 
that was not revealed by the original analysis in the mouse (4), and that may point to an un- 
suspected connection between Gross virus and certain leukemias of the mouse whose etiology 
is uncertain. 
Precipitating Antibody in the Serum of Adult Inbred W/Fu Rats Immunized 
with Isogenic  Induced W/Fu Rat Leukemias.--Precipitating  activity  was  first 764  ANTIGENS  Ok"  LEUKEMIAS 
detected in the sera of adult W/Fu rats that had received multiple inoculations 
of  the  isogenic  leukemia  W/Fu(C58NT)D  and  had  provided  the  cytotoxic 
antisera described above. Fig. 1 a shows the reactions observed with 5 different 
antisera  in  an  immunodiffusion  test with  antigen  prepared from the  induced 
rat leukemia W/Fu(C58NT)I.  Precipitation occurred with the antisera W/Fu 
anti-W/Fu(C58XT)D  and W/Fu anti-W/Fu(AKR-SL)F.  A  rat  isoantiserum 
against  a  W/Fu  spontaneous  (G--)  leukemia,  BN  anti-W/Fu(SL)7,  and  a 
W/Fu antiserum against G-- normal mouse tissue, were negative. No precipi- 
tating activity was demonstrable in the mouse G typing serum C57BL/6 anti- 
K3~  (AKR leukemia). 
Concentrated extracts for immunodiffusion tests (see Materials and Methods) 
were prepared from a variety of G+  and G--  sources; a  total of 127  extracts 
have been studied. The 77 G-I- extracts comprised 34 prepared from the tissues 
or plasma of W/Fu  or BN rats with leukemia induced  by the inoculation  of 
mouse cells,  and 43 from mouse tissues or plasma (18 from AKR primary spon- 
taneous leukemias and 12 from plasma or serum of these leukemic mice; 2 from 
lymphoid tissue of normal AKR mice; 2 from C58 primary leukemias and 1 from 
the serum of these leukemic mice; 5 from C3Hf/Bi leukemias induced by Pas- 
sage A Gross virus and 3 from a transplanted C57BL leukemia induced by Pas- 
sage A  Gross virus, E  c?  G2). These 77  G+  extracts invariably gave positive 
reactions (and reactions of identity)  in immunodiffusion tests  with the precipi- 
tating rat antisera (see Fig. 1 b). The unconcentrated serum or plasma of primary 
leukemic animals may give positive reactions with precipitating rat antiserum; 
this is more common u ith the serum of leukemic rats than with  the serum of 
leukemic mice. 
The  50  concentrated  G--  extracts  were  prepared  from different  tissues  of 
mice of G-  strains (C57BL/6, DBA/2, C3Hf/Bi, C3H/An and I), and of BN 
and  W/Fu  rats.  These  included  separate  extracts  of  thymus,  spleen,  lymph 
nodes, kidney, liver, and brain of normal mice or rats, extracts of G-- leukemias, 
and extracts of mammary tumors from mice of strains that carry MTV (Bittner 
virus).  None gave a  reaction with precipitating antisera;  tests with 4 of these 
preparations are illustrated in Fig.  1 c. 
There was no correlation between the cytotoxic and  precipitating activities 
of the  rat  immune sera  (Table V).  Some precipitating sera had  no cytotoxic 
activity and  some cytotoxic sera had no  demonstrable precipitating activity. 
Of the examples shown in Table V,  the serum with the highest cytotoxic tiler 
had no precipitating activity. 
Reactions of Precipitating W/Fu A ntisera with Intact and Ether-Treated Gross 
Virus (Fig. 2 a).--Seven different preparations of virus were made by resuspen- 
sion of pellets obtained by centrifugation of plasma from C3Hf/Bi mice with 
primary leukemia induced by Passage  A  Gross virus  (as described under Ma 
terials and Methods). No precipitation lines were observed when the fresh prep- 
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However, faint lines were obtained with preparations that had been frozen and 
thawed.  Samples of the  same  preparations were  then  treated with ether  and 
were now found to give a strong precipitation line showing reactions of identity 
with G antigen prepared from both AKR spontaneous leukemia and  from  G+ 
TABLE V 
Cytotoxic Tiler and Precipitating Activity of Sera from Individual W/Fu Rats 
Immunized with the Isogenic Leukemia W/Fu(C58NT)D 
W/Fu o  ~ rat No.:  (No. of inoculations)  Cytotoxic  tiler (reciprocal)*  Precipitating activitykt 
3549 (12) 
3639 (1 l) 
3486 (9) 
3422 (11) 
3639 (9) 
3547 (12) 
3549 (8) 
3486 (11) 
3410 (11) 
3420 (11) 
3547 (8) 
3485 (9) 
3485 (11) 
3545 (12) 
3548 (12) 
3484 (11) 
3440 (9) 
3440 (11) 
343O (11) 
3306 (11) 
3484 (9) 
<2 
<2 
<2 
<2 
2 
4 
4 
4 
4 
4 
8 
8 
8 
8 
8 
16 
16 
16 
16 
16 
32 
+ 
+ 
+ 
+++ 
++ 
+ 
* End point: 50%  W/Fu(C58NT)D ascites cells stained by trypan blue; all sera inacti- 
vated at 56°C and all tested on the same day with the same suspension of W/Fu(C58NT)D 
cells. 
:~ Ouchterlony  technique;  antigen  prepared from  W/Fu(C58NT)D  leukemia cells  (see 
text); all tests performed  on same day with same preparation of antigen, and read at 48 hr. 
--, no precipitation; +, faint reaction; ÷+,  strong reaction; ++÷,  very strong reaction. 
induced rat leukemias. Sediment obtained from the plasma of normal C3Hf/Bi 
mice by centrifugation at  100,000  g for  1 hr, resuspended and treated with ether 
as in the  case  of the  pellets from  leukemic C3Hf/Bi  mice,  gave  no  reaction. 
Precipitating activity was removed from positive sera by the addition of ether- 
treated virus, but not by the addition of equivalent quantities of untreated virus. 
Reactions  of  W/Fu  Precipitating  G  Antisera  with Intact and Ether-Treated 
Friend, Moloney, Rauscher,  and Bittner  (Mcmmary  Tumor)  Viruses.--As  with 766  ANTIGENS  OF LEUKEMIAS 
Gross virus, no lines of precipitation occurred with pellets of intact virus pre- 
pared by centrifugation of plasma from mice with Friend or Rauscher leukemias 
or from W/Fu  rats with primary Moloney leukemias. Intact virus (MTV)from 
the  milk of RIII  mice also  gave  no  reaction.  After treatment  of  the  pellets 
with  ether,  however,  lines  of  precipitation  were  observed  with  Friend, 
FIG. 2 a. Center  (C), serum W/Fu anti-G+ leukemia W/Fu(C58NT)D. 
(1) Freshly prepared untreated pellet from plasma of C3Hf/Bi mice with primary leuke- 
mia induced  by Passage  A  Gross  virus.  (2)  Same preparation after treatment with ether. 
(3) Extract of pooled primary G+ AKR leukemias.  (4) Extract of G+  transplanted W/Fu 
leukemia W/Fu(C58NT)D.  (5) Ether-treated pellet from plasma of normal C3Hf/Bi mice. 
FIG. 2 b. Center (C), serum W/Fu anti-G+ leukemia W/Fu(C58NT)D. 
Ether-treated pellet from:  (1)  plasma of C3Hf/Bi  mice with primary leukemia induced 
by Passage A Gross virus; (2) plasma of DBA/2 mice with Friend virus leukemia;  (3) plasma 
of W/Fu rats with primary Moloney virus leukemia;  (4) plasma of BALB/c mice with Rau- 
scher virus leukemia;  and  (5)  MTV separated by density-gradient centrifugation from  milk 
of MTV-infected  mice (RIII strain). 
Fro. 2 c. Center (C), serum of (W/Fu)< BN)F1 hybrid bearing large subcutaneous  growth 
of G+ leukemia W/Fu(C58NT)D. 
(1)  Freshly  prepared  untreated  pellet  from  plasma  of  primary  G+  leukemia 
W/Fu(C58NST*)4.  (2)  Same preparation after treatment with ether.  (3) Extract of trans- 
planted G+ leukemia W/Fu(C58NST*)2.  (4) Extract of transplanted G+ leukemia W/Fu 
(C58NT)D.  (5)  Concentrate  of ascites  fluid  from  the  transplanted  G+  W/Fu  leukemia 
W/Fu(C58NST*) 1. 
* From a series of W/Fu leukemias induced by inoculation of C58 normal spleen and thy- 
mus cells (C58NST). 
Moloney, and Rauscher viruses, but not  with  MTV.  Fig.  2 b  shows reactions 
of identity with W/Fu  precipitating G  antiserum and  ether-treated  pellets of 
Gross, Friend, Moloney, and Rauscher viruses. 
Cylotoxic  and Precipitating Antibodies  in  the  Serum  of Adult Rats  Bearing 
Transplants of the Induced Leukemia W/Fu(C58NT)D.--Recently the induced 
W/Fu  leukemia W/Fu(C58NT)D,  that  has  been  maintained  by ascites pas- 
sage in W/Fu  hosts aged 10 to 15 days, acquired the ability to grow subcutane- 
ously or intraperitioneally in adult W/Fu  or W/Fu  hybrid rats.  Some  trans- 
plants grow progressively and some ultimately regress. In both instances,  but GAYLA GEERZNG~ LLOYD 7"  OLD~ AND  EDWARD  A.  BOYSE  767 
particularly in the case of rats with progressively growing subcutaneous trans- 
plants,  the serum contains very high levels of cytotoxic G  antibody (titers 
ranging from 1/512 to 1/2048 against the C57BL/6 typing leukemia E o~G2). 
In immunodiffusion tests with a variety of extracts from G-k sources these sera 
produce 5 distinct precipitin  lines. Three of these are distinctly visible in Fig. 
2 c. (Two other components were visible on this plate but cannot be seen in the 
figure.) The component that is common to preparations 2 to 5 in Fig. 2 c is the 
group-specific component of the leukemia viruses illustrated in Fig. 2 b. Fig. 
2 c shows once again that ether-treatment is  required  to release  this antigen 
from intact virus. 
DISCUSSION 
The rat is highly susceptible to mouse leukemia viruses, and the leukemias 
they induce are in general similar to those that occur in the mouse (see reference 
15). The W/Fu rat has only a low incidence of spontaneous lenkemias and in our 
hands procedures that are highly effective in inducing leukemia in mice--frac- 
tional X-radiation, percutaneous application of 9,10-dimethyl-1,2-benzanthra- 
cene, and injection of urethan during the neonatal period--do not raise  this 
incidence appreciably.  If these procedures are leukemogenic in  the mouse be- 
cause they activate latent virus, as is commonly believed, then their failure to 
be effective in W/Fu rats might be taken to indicate the absence of viruses of 
similar type. The absence of such virus,  together with the considerable send- 
tivity of W/Fu rats to routine leukemia  viruses,  may suggest  that they are 
favorable hosts for the isolation of leukemia viruses,  t 
Leukemias may be induced in rats not only by the inoculation of infective 
filtrates of mouse cells but also by the inoculation of viable ceils. Kirsten and 
Platz (17) induced leukemias by inoculating ceUs of spontaneous  leukemias of 
AKR mice, and those appearing  13 to 20 wk later were shown by transplanta- 
tion tests to be composed of rat cells. We find that normal cells from the thymus 
of C58 mice, which carry Gross virus, are as effective as leukemia ceUs, the inci- 
dence of leukemla in W/Fu recipients being as high as 100% in some experi- 
ments. These primary leukemias  occurring  as a  result of the inoculation  of 
mouse leukemia ceils or of mouse thymus celis presumably are induced by virus 
released from the inoculated cells before their rejection. The strong antigenicity 
of the induced leukemias,  indicated by their failure  to grow progressively in 
adult recipients, ~  is characteristic  also of some leukemias induced in W/Fu rats 
by rat-adapted Passage A Gross virus (15). Antigenicity of this degree is not 
1 In this context, Huggins and Sugiyama recently demonstrated that a  high inddence of 
leukemia can be induced in Long-Evans rats by multiple small intravenous doses of DMBA 
(16). The susceptibility of W/Fu rats to this procedure is not known. 
s For unknown  reasons,  the leukemias induced by Kirsten and  Platz were freely trans- 
plantable in adult recipients (17). 768  ANTIGENS  OF  LEUKEM~IAS 
seen with leukemias induced by Gross virus in the mouse, whether they are 
induced by neonatal inoculation of Passage A Gross virus or arise spontaneously 
in mice of strains that carry Gross virus (the high-incidence G~  strains such 
as AKR and C58).  This difference in behavior of leukemlas induced by Gross 
virus in the rat and in the mouse may be ascribed to the fact that the rat is not 
the natural host of Gross virus; under natural conditions in the mouse it seems 
likely that a virus with minimal antigenicity has been selected, and that this is 
reflected in the induction of leukemias that are poorly antigenic. 
Direct cytotoxic tests and absorption analysis with cytotoxic antisera pre- 
pared in adult rats by repeated inoculations of isogenic leukemia cells showed 
positive reactions with all cells previously typed G-b  in the mouse G  typing 
system (4). However, several G--  leukemias absorbed cytotoxic activity from 
the rat immune serum. This points to the presence of more than one character- 
istic antigenic determinant on leukemia cells induced by Gross virus. The G-- 
leukemias that are positive when tested with the rat immune system evidently 
lack one of the determinants detected by the mouse system and so fail to re- 
move all cytotoxic activity from the mouse G typing serum. This determinant, 
however, is responsible for the major reaction in the rat cytotoxic system and 
consequently all cytotoxic activity is absorbed by these leukemias. According 
to this view the mouse G typing system recognizes predominantly the speci- 
ficity G(a), whereas the rat typing system recognizes predominantly G(b). Al- 
though there is no certainty as to the nature of the G cellular antigens respon- 
sible for cytotoxicity it is probable that they are proteins of the viral coat that 
are incorporated in the cell membrane. The different specificities  revealed by 
the use of mouse and rat antisera may thus be evidence of antigenic variants 
of Gross virus. 
In addition to its cytotoxic activity, rat immune serum precipitates antigen 
prepared from G-t-  tissues. This antigen cannot be intact Gross virus, because 
it is prepared from material that had been centrifuged under conditions known 
to remove intact virus. Furthermore, Passage A Gross virus prepared from in- 
fective plasma does not react with precipitating antibody in immunodiffusion 
tests. The antigen is present in these preparations of virus, however, because 
treatment with ether yields an antigen which is precipitated by rat antiserum. 
As shown by reactions of identity, this antigen from ether-treated virus prepa- 
rations is the same as that obtained from G-k  cells. Precipitating antibody is 
absorbed by ether-treated preparations of virus, but not by equivalent quanti- 
ties of untreated virus preparations. (This lessens the possibility that the failure 
of intact virus to react in immunodiffusion tests can be explained solely by its 
failure to penetrate the agar.) The conclusion is that the precipitating antibody 
is directed towards an internal component of Gross virus that is present also, 
in the free state, in cells infected with Gross virus. The same antigenic deter- 
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not in mammary tumor virus); once again it is not demonstrable in untreated 
preparations of these leukemia viruses, but is released by treatment of these 
preparations with ether. The most direct explanation of the cross-reactions seen 
in  immunodiffusion is  that  these  viruses share an internal component com- 
parable to the group antigens of other classes of virus. 
Analysis of the surface antigens of the virus can be approached by the use of 
antisera in neutralization tests with the various leukemia viruses. For study of 
surface antigens of the virion the W/Fu rat antisera have a  unique value be- 
cause they are formed against isogenic W/Fu rat leukemia cells and so cannot 
contain antibodies against any normal constituents of the cell membrane that 
may be incorporated in the virion. Antisera prepared by repeated inoculation 
of isogenic leukemia cells  into  adult resistant  rats  have strong neutralizing 
activity against Passage A Gross virus;--in fitrations of Passage A Gross virus 
in C3Hf/Bi newborn mice, pooled immune rat serum has completely neutral- 
ized the activity of a filtrate which had an ID~ (leukemia induction, observa- 
tion period 240 days) of 3.5 log units. We are now studying the neutralizing 
activity of  this  antiserum against  Friend,  Moloney, and  Ranscher viruses. 
Antisera of this sort had little or no neutralizing activity for Rauscher virus. 
However, the more recently available high-titer antisera obtained from rats 
with  large  growing  transplants  have  appreciable  neutralizing  activity  for 
Rauscher virus. These results are to be expected if these viruses are character- 
ized by both shared and distinct surface antigens. 
The leukemia viruses have been compared with myxoviruses, especially on 
the grounds of their similar modes of replication. It may be that further paral- 
lels can be drawn with regard to their antigenic structure. Myxovirus antigens 
include V antigen, which is present in the virus coat where the components re- 
sponsible for hemagglutination and neuraminidase activity are situated, and 
the internal ribonucleoprotein g antigen. Both have their counterpart in  the 
infected cell, which contains free s antigen, thought to be identical to viral g 
antigen, and also V antigen attached to the endoplasmic reticulum, in addition 
to virus forming at the cell surface (18). One of the main difficulties in effecting 
a  comparable separation of components of the leukemia viruses is that these 
viruses lack readily demonstrable hemadsorption activity. Thus further de- 
scription of the leukemia virus antigens will depend upon the morphological 
identification of antigenically distinct components separated by other methods. 
The simplest formulation that accounts for the serological  reactions of the 
rat antisera is that neutralizing and cytotoxic antibodies are reacting with the 
same viral antigens, which are situated in the coat of the virion and are in- 
corporated in the surface membranes of infected ceils; antibodies of different 
specificities are identified in immunodiffusion tests by precipitation with anti- 
gen which is present in soluble form in infected cells and which can be released 
by ether-treatment of the virion (Figs. 1 a to 1 c and 2 a to 2 c). However, there 770  ANTIGENS OF I~IYKE~A.S 
are other findings that must be accommodated in any coherent account of the 
routine leukemia antigens. 
1.  The mouse  G typing serum C57BL/6 anti-(AKR)K36 is cytotoxic but 
has  little  neutralizing activity and  no  demonstrable  precipitating  activity. 
This may indicate that mice of G-  strains are tolerant of some determinants, 
possibly as a result of endemic infection with related viruses, and so can be im- 
mtmized against only those determinants that distinguish the inoculated virus 
or the inoculated histoincompatible  leukemia  cell from viruses  indigenous in 
the strain. 
2.  The class of soluble antigens that is detected by adsorption to viable in- 
dicator cells (19) is divisible into FMR and G types (2), in parallel  with the 
results of cytotoxic tests (14). This contrasts with the common antigen detected 
by immunodiffusion in ether-treated Gross, Friend, Moloney, and Rauscher 
viruses, and in leukemias induced by these viruses. 
The former may be analogous to the V antigen of myxoviruses, displaying 
capacity to adsorb  to cell surfaces and type-specificity.  The antigen showing 
group-specificity in immunodiffusion may, as suggested above,  be comparable 
with the s antigen (cellular g antigen) of myxoviruses. 
3.  Our recent experience with the serum of adult rats bearing growing trans- 
plants indicates that at least 5 antigens can be detected by immunodiffusion 
with concentrated extracts of G-t- leukemias of mouse and rat. One of these is 
the antigen demonstrable  with serum from rats ~mmuniz~d  by repeated inocu- 
lations of isogenic leukemia cells and is the component found both in leukemia 
cells and in  ether-treated preparations  of the  Gross,  Friend,  Moloney, and 
Rauscher viruses. Whether the other 4 are antigens of the virion  or nonvirion 
antigens produced  in the cell under the direction  of the viral genome or the 
genome of the leukemia cell is not yet known. 
SUMMARY 
Leukemias can be induced in W/Fu inbred rats by neonatal inoculation  of 
normal thymus cells of C58 mice. These leukemias are not transplantable to 
C58 mice or to adult W/Fu rats, but they can be kept in passage in W/Fu rats 
aged 0 to 7 days. Adult W/Fu rats inoculated repeatedly with these isogenic 
leukemias  produce  cytotoxic and precipitating antibodies.  These  antisera are 
of particular value in the analysis of the antigens of leukemia cells and of leu- 
kemia viruses  because  their mode of preparation precludes  the formation of 
antibody against any normal constituents of the cell. 
Analysis based on the cytotoxic test indicates the presence of 2 distinct cell 
surface antigens in leukemias induced by Passage A Gross virus or occurring 
spontaneously in mice of high-incidence strains. All leukemias and other tissues 
known to contain G  (Gross) leukemia  antigen have both determinants, but 
certain leukemias  of low-incidence strains have only 1 of them and so were 
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Immunoprecipitation with these antisera reveals the presence of a  cellular 
antigen common to G+ cells and absent from G-- cells; the same antigen can 
be demonstrated in ether-treated Gross virus, but not in intact virus. This anti- 
gen is present also in ether-treated preparations of the Friend, Moloney, and 
Ranscher leukemia viruses, but not in Bittner (mammary tumor) virus. Thus 
it may be regarded as a  group-specific antigen of murine leukemia viruses, in 
contrast to the type-specific cellular antigens  demonstrable  by  the  cytotoxic 
test. Four additional antigens associated with leukemias induced by wild-type 
Gross virus have  been  demonstrated  by  immunoprecipitation,  but their re- 
lation to viral and cellular antigens has not been determined  ..... 
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